Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

被引:362
作者
Wu, XD
Motoshima, H
Mahadev, K
Stalker, TJ
Scalia, R
Goldstein, BJ
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Div Endocrinol Diabet & Metab Dis, Dorrance H Hamilton Res Labs,Dept Med, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Physiol, Philadelphia, PA 19107 USA
关键词
D O I
10.2337/diabetes.52.6.1355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adiponeetin is an abundant adipocyte-derived plasma protein with anti-atherosclerotic and insulin-sensitizing properties that, suppresses hepatic glucose production and enhances glucose uptake into skeletal muscle. To characterize the potential effects of adiponectin on glucose uptake into adipose cells, we incubated isolated epididyinal rat adipocytes with the globular domain of recombinant adiponectin purified from an E. coli expression,system. Globular adiponectin increased glucose uptake in adipocytes without stimulating tyrosine phosphorylation of the insulin receptor or insulin receptor substrate-1, and without enhancing phosphorylation of Akt on Ser-473. Globular adiponectin further enhanced, insulin-stimulated glucose uptake at submaximal insulin concentrations and reversed the inhibitory effect of tumor necrosis,factor-a on insulin-stimulated glucose uptake. Cellular treatment with globular adiponectin increased the Thr-172 phosphorylation and catalytic activity of AMP-activated protein kinase and enhanced the Ser-79 phosphorylation of acetyl CoA carboxylase; an enzyme downstream of AMP kinase in Adipose cells. Inhibition of AMP kinase activation using two pharmacological inhibitors (adenine 9-beta-D-axabinofuranoside and compound C) completely abrogated the increase in glucose uptake. stimulated by globular adiponectin, indicating that AMP kinase is integrally involved in the adiponectin signal transduction pathway. Coupled with recent evidence that the effects of adiponectin are mediated via AMP kinase activation in liver and skeletal muscle; the findings reported here provide an important mechanistic link in the signaling effects of adiponectin in diverse metabolically responsive tissues.
引用
收藏
页码:1355 / 1363
页数:9
相关论文
共 59 条
[41]   Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes [J].
Sakoda, H ;
Ogihara, T ;
Anai, M ;
Fujishiro, M ;
Ono, H ;
Onishi, Y ;
Katagiri, H ;
Abe, M ;
Fukushima, Y ;
Shojima, N ;
Inukai, K ;
Kikuchi, M ;
Oka, Y ;
Asano, T .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (06) :E1239-E1244
[42]   5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes [J].
Salt, IP ;
Connell, JMC ;
Gould, GW .
DIABETES, 2000, 49 (10) :1649-1656
[43]   The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor [J].
Shapiro, L ;
Scherer, PE .
CURRENT BIOLOGY, 1998, 8 (06) :335-338
[44]   Obesity and the regulation of energy balance [J].
Spiegelman, BM ;
Flier, JS .
CELL, 2001, 104 (04) :531-543
[45]   Mammalian AMP-activated protein kinase subfamily [J].
Stapleton, D ;
Mitchelhill, KI ;
Gao, G ;
Widmer, J ;
Michell, BJ ;
Teh, T ;
House, CM ;
Fernandez, CS ;
Cox, T ;
Witters, LA ;
Kemp, BE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :611-614
[46]  
Statnick M A, 2000, Int J Exp Diabetes Res, V1, P81, DOI 10.1155/EDR.2000.81
[47]   Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans [J].
Stefan, N ;
Vozarova, B ;
Funahashi, T ;
Matsuzawa, Y ;
Weyer, C ;
Lindsay, RS ;
Youngren, JF ;
Havel, PJ ;
Pratley, RE ;
Bogardus, C ;
Tataranni, PA .
DIABETES, 2002, 51 (06) :1884-1888
[48]  
Tanti JF, 2000, METH MOL B, V155, P157
[49]  
TOMA SE, 2002, P NATL ACAD SCI USA, V99, P16309
[50]   ACRP30, a new hormone controlling fat and glucose metabolism [J].
Tsao, TS ;
Lodish, HF ;
Fruebis, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :213-221